17β hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma

► HSD17B12 expression was studied in OvCa tissues and cell lines. ► Weak/moderate HSD17B12 expression correlated with better OS and longer TTR. ► Silencing of HSD17B12 in tumor cells induced growth inhibition and apoptosis.